Study of a blood test to guide heart stent treatment
Part of Heart & circulation, Pain clinical trials.
This trial is looking at whether a blood test can help doctors choose the best treatment for people with heart disease who are getting stents. It may help make treatment more personal and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You have stable angina (chest pain) or a test showing reduced blood flow to your heart, or you recently had a mild heart attack (non-ST elevation ACS) that is getting better.
- You are able to take a blood thinner (aspirin plus another one like clopidogrel, prasugrel, or ticagrelor).
- Your doctor expects you to live at least another year.
- You have not had a severe heart attack (STEMI) in the last week.
- You have not had a stent procedure in the last week.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests different blood thinner medicines after a heart stent is placed. It aims to find the best way to prevent blood clots while reducing bleeding risk.
This Phase 4 study tests a way to measure blood flow in heart arteries to help doctors choose the best stent plan. It may help improve safety and effectiveness for people having elective heart stent procedures for stable angina or certain heart attacks.
This study looks at new blood tests (biomarkers) that may predict whether blood flow will be blocked again after a stent procedure for a heart attack. It could help doctors improve treatment and recovery.
This study compares two ways of guiding a heart stent procedure: using information from a special angiography scan versus using standard practice. It may help your care team choose the best treatment to improve heart outcomes after stenting.
This trial tests whether a low-dose clot-busting medicine placed into the heart artery after a primary stent can improve outcomes in people with a certain type of heart attack. It also involves short hospital follow-ups and a heart MRI to look at how the heart is recovering.
This study looks at whether a simple blood test measure (the triglyceride glucose index, which relates to blood sugar and fats) can help predict how much heart damage remains after emergency stent treatment for a heart attack. If you fit the criteria, joining may help doctors understand more about recovery and future risks.
Hear when a new Mortality trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.